
Abbott (ABT) currently holds an average brokerage recommendation (ABR) of 1.48, approximating a Strong Buy, based on ratings from 25 brokerage firms; however, the article suggests that investors should be cautious when relying solely on ABRs due to inherent biases from brokerage firms. The Zacks Rank, driven by earnings estimate revisions, is presented as a potentially more reliable indicator, and Abbott currently holds a Zacks Rank #3 (Hold), with the consensus earnings estimate for the current year remaining unchanged at $5.16.
Abbott (ABT) exhibits a strong Average Brokerage Recommendation (ABR) of 1.48, positioning it between a Strong Buy and Buy, based on the consensus of 25 brokerage firms where 18 advocate a Strong Buy and two a Buy. This apparent optimism from sell-side analysts, however, is contrasted by the article's cautionary perspective on ABRs, highlighting potential inherent biases due to brokerage firms' vested interests and historical data suggesting a disproportionate ratio of five Strong Buy recommendations for every Strong Sell. The article posits the Zacks Rank, a quantitative model driven by earnings estimate revisions, as a potentially more reliable indicator. For Abbott, the Zacks Rank is #3 (Hold), influenced by an unchanged Zacks Consensus Estimate for current year earnings at $5.16 over the past month. This stability in earnings estimates suggests Abbott's stock may perform in line with the broader market in the near term, a less bullish outlook than the ABR implies. The overall sentiment is mixed, reflecting this divergence between analyst ratings and earnings estimate trends.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment